Similar articles

• Intrathecal baclofen therapy in children with cerebral palsy.

  Brown TR. Brown TR. Arch Phys Med Rehabil. 2003 Apr;84(4):624; author reply 624. doi: 10.1053/apmr.2003.50238. Arch Phys Med Rehabil. 2003. PMID: 12690609 No abstract available.
• [Intrathecal baclofen for treatment of spasticity in patient with cerebral palsy--a preliminary report].

  Jóźwiak M, Idzior M, Huber J, Szulc A, Grottel K. Jóźwiak M, et al. Chir Narzadow Ruchu Ortop Pol. 2003;68(4):253-9. Chir Narzadow Ruchu Ortop Pol. 2003. PMID: 14702678 Polish.
• Intrathecal L-baclofen for cerebral spasticity: case report.

  Albright AL, Barry MJ, Hoffmann P. Albright AL, et al. Neurology. 1995 Nov;45(11):2110-1. doi: 10.1212/wnl.45.11.2110. Neurology. 1995. PMID: 7501170 No abstract available.
• Evidence of the effects of intrathecal baclofen for spastic and dystonic cerebral palsy. AACPDM Treatment Outcomes Committee Review Panel.

  Butler C, Campbell S. Butler C, et al. Dev Med Child Neurol. 2000 Sep;42(9):634-45. doi: 10.1017/s0012162200001183. Dev Med Child Neurol. 2000. PMID: 11034458 Review. No abstract available.
• Intrathecal baclofen therapy for spastic hypertonia.

  Ivanhoe CB, Tilton AH, Francisco GE. Ivanhoe CB, et al. Phys Med Rehabil Clin N Am. 2001 Nov;12(4):923-38, viii-ix. Phys Med Rehabil Clin N Am. 2001. PMID: 11727722 Review.